Authors:
Shinozuka, Y
Okada, M
Oki, T
Sagane, K
Mizui, Y
Tanaka, I
Katayama, K
Murakami-Murofushi, K
Citation: Y. Shinozuka et al., Altered expression of HES-1, BETA2/NeuroD, and PDX-1 is involved in impaired insulin synthesis induced by glucocorticoids in HIT-T15 cells, BIOC BIOP R, 287(1), 2001, pp. 229-235
Authors:
Kobayashi, T
Tanaka-Ishii, R
Taguchi, R
Ikezawa, H
Murakami-Murofushi, K
Citation: T. Kobayashi et al., Existence of a bioactive lipid, cyclic phosphatidic acid, bound to human serum albumin, LIFE SCI, 65(21), 1999, pp. 2185-2191
Authors:
Bandoh, K
Aoki, J
Hosono, H
Kobayashi, S
Kobayashi, T
Murakami-Murofushi, K
Tsujimoto, M
Arai, H
Inoue, K
Citation: K. Bandoh et al., Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid, J BIOL CHEM, 274(39), 1999, pp. 27776-27785
Authors:
Mukai, M
Imamura, F
Ayaki, M
Shinkai, K
Iwasaki, T
Murakami-Murofushi, K
Murofushi, H
Kobayashi, S
Yamamoto, T
Nakamura, H
Akedo, H
Citation: M. Mukai et al., Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA), INT J CANC, 81(6), 1999, pp. 918-922
Authors:
Fischer, DJ
Liliom, K
Guo, Z
Nusser, N
Virag, T
Murakami-Murofushi, K
Kobayashi, S
Erickson, JR
Sun, GP
Miller, DD
Tigyi, G
Citation: Dj. Fischer et al., Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes, MOLEC PHARM, 54(6), 1998, pp. 979-988